GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Shanghai Pioneer Holding Ltd (HKSE:01345) » Definitions » Debt-to-Equity

Shanghai Pioneer Holding (HKSE:01345) Debt-to-Equity : 0.07 (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Shanghai Pioneer Holding Debt-to-Equity?

Shanghai Pioneer Holding's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$67 Mil. Shanghai Pioneer Holding's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$14 Mil. Shanghai Pioneer Holding's Total Stockholders Equity for the quarter that ended in Dec. 2023 was HK$1,101 Mil. Shanghai Pioneer Holding's debt to equity for the quarter that ended in Dec. 2023 was 0.07.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Shanghai Pioneer Holding's Debt-to-Equity or its related term are showing as below:

HKSE:01345' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02   Med: 0.06   Max: 0.55
Current: 0.07

During the past 12 years, the highest Debt-to-Equity Ratio of Shanghai Pioneer Holding was 0.55. The lowest was 0.02. And the median was 0.06.

HKSE:01345's Debt-to-Equity is ranked better than
84% of 550 companies
in the Healthcare Providers & Services industry
Industry Median: 0.485 vs HKSE:01345: 0.07

Shanghai Pioneer Holding Debt-to-Equity Historical Data

The historical data trend for Shanghai Pioneer Holding's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pioneer Holding Debt-to-Equity Chart

Shanghai Pioneer Holding Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.02 0.02 0.04 0.07

Shanghai Pioneer Holding Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.08 0.04 0.10 0.07

Competitive Comparison of Shanghai Pioneer Holding's Debt-to-Equity

For the Pharmaceutical Retailers subindustry, Shanghai Pioneer Holding's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Pioneer Holding's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Shanghai Pioneer Holding's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Shanghai Pioneer Holding's Debt-to-Equity falls into.



Shanghai Pioneer Holding Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Shanghai Pioneer Holding's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Shanghai Pioneer Holding's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Pioneer Holding  (HKSE:01345) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Shanghai Pioneer Holding Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Shanghai Pioneer Holding's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Pioneer Holding (HKSE:01345) Business Description

Traded in Other Exchanges
N/A
Address
No.15, Lane 88 Wuwei Road, Putuo District, Shanghai, CHN, 200331
Shanghai Pioneer Holding Ltd is an investment holding company. It is engaged in the marketing, promotion, sales, and channel management service for pharmaceutical products and medical devices in China. The company has a portfolio of pharmaceutical products, covering ophthalmology, pain management, cardiovascular, gastroenterology, immunology, gynecology, and other therapeutic areas, and medical devices covering several medical specialties, including ophthalmology, orthopedics, odontology, and wound care. The majority of its revenue derives from the Sales of pharmaceutical products segment. The group operates mainly in PRC.

Shanghai Pioneer Holding (HKSE:01345) Headlines

No Headlines